• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类诺如病毒:感染的实验模型。

Human Norovirus: Experimental Models of Infection.

机构信息

Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, GA 30602, USA.

出版信息

Viruses. 2019 Feb 12;11(2):151. doi: 10.3390/v11020151.

DOI:10.3390/v11020151
PMID:30759780
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6410082/
Abstract

Human noroviruses (HuNoVs) are a leading cause of acute gastroenteritis worldwide. HuNoV infections lead to substantial societal and economic burdens. There are currently no licensed vaccines or therapeutics for the prevention or treatment of HuNoVs. A lack of well-characterized and infection models has limited the development of HuNoV countermeasures. Experimental infection of human volunteers and the use of related viruses such as murine NoV have provided helpful insights into HuNoV biology and vaccine and therapeutic development. There remains a need for robust animal models and reverse genetic systems to further HuNoV research. This review summarizes available HuNoV animal models and reverse genetic systems, while providing insight into their usefulness for vaccine and therapeutic development.

摘要

人类诺如病毒(HuNoVs)是全球急性胃肠炎的主要原因。HuNoV 感染会导致巨大的社会和经济负担。目前尚无针对 HuNoVs 的预防或治疗的许可疫苗或疗法。缺乏特征明确和感染模型限制了 HuNoV 对策的开发。人类志愿者的实验感染以及相关病毒(如鼠诺如病毒)的使用为 HuNoV 生物学以及疫苗和治疗方法的开发提供了有价值的见解。仍然需要强大的动物模型和反向遗传系统来进一步研究 HuNoV。本文综述了现有的 HuNoV 动物模型和反向遗传系统,并探讨了它们在疫苗和治疗开发方面的应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed2b/6410082/89edfcf7afea/viruses-11-00151-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed2b/6410082/89edfcf7afea/viruses-11-00151-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed2b/6410082/89edfcf7afea/viruses-11-00151-g001a.jpg

相似文献

1
Human Norovirus: Experimental Models of Infection.人类诺如病毒:感染的实验模型。
Viruses. 2019 Feb 12;11(2):151. doi: 10.3390/v11020151.
2
A Lactic Acid Bacteria (LAB)-Based Vaccine Candidate for Human Norovirus.基于乳酸菌的人类诺如病毒疫苗候选物。
Viruses. 2019 Mar 2;11(3):213. doi: 10.3390/v11030213.
3
New interventions against human norovirus: progress, opportunities, and challenges.新型抗人类诺如病毒干预措施:进展、机遇与挑战。
Annu Rev Food Sci Technol. 2012;3:331-52. doi: 10.1146/annurev-food-022811-101234. Epub 2011 Nov 7.
4
Development of a reverse-genetics system for murine norovirus 3: long-term persistence occurs in the caecum and colon.建立鼠诺如病毒 3 的反向遗传学系统:长期存在于盲肠和结肠中。
J Gen Virol. 2012 Jul;93(Pt 7):1432-1441. doi: 10.1099/vir.0.042176-0. Epub 2012 Apr 11.
5
Progress on norovirus vaccine research: public health considerations and future directions.诺如病毒疫苗研究进展:公共卫生方面的考虑因素和未来方向。
Expert Rev Vaccines. 2018 Sep;17(9):773-784. doi: 10.1080/14760584.2018.1510327. Epub 2018 Aug 27.
6
B-Cell Responses to Intramuscular Administration of a Bivalent Virus-Like Particle Human Norovirus Vaccine.B细胞对肌内注射二价病毒样颗粒人诺如病毒疫苗的反应。
Clin Vaccine Immunol. 2017 May 5;24(5). doi: 10.1128/CVI.00571-16. Print 2017 May.
7
Recent advances in human norovirus research and implications for candidate vaccines.人类诺如病毒研究的最新进展及其对候选疫苗的影响。
Expert Rev Vaccines. 2020 Jun;19(6):539-548. doi: 10.1080/14760584.2020.1777860. Epub 2020 Jun 18.
8
[Noroviruses: leading cause of gastroenteritis].[诺如病毒:肠胃炎的主要病因]
Med Trop (Mars). 2010 Apr;70(2):111-8.
9
Replication of Human Norovirus RNA in Mammalian Cells Reveals Lack of Interferon Response.人类诺如病毒RNA在哺乳动物细胞中的复制揭示了其缺乏干扰素反应。
J Virol. 2016 Sep 12;90(19):8906-23. doi: 10.1128/JVI.01425-16. Print 2016 Oct 1.
10
Therapeutics and Immunoprophylaxis Against Noroviruses and Rotaviruses: The Past, Present, and Future.针对诺如病毒和轮状病毒的治疗与免疫预防:过去、现在与未来
Curr Drug Metab. 2018;19(3):170-191. doi: 10.2174/1389200218666170912161449.

引用本文的文献

1
Virus Shedding and Diarrhea: A Review of Human Norovirus Genogroup II Infection in Gnotobiotic Pigs.病毒脱落与腹泻:人诺如病毒基因Ⅱ组感染无菌猪的研究综述。
Viruses. 2024 Sep 7;16(9):1432. doi: 10.3390/v16091432.
2
A quadrivalent norovirus vaccine based on a chimpanzee adenovirus vector induces potent immunity in mice.基于黑猩猩腺病毒载体的四价诺如病毒疫苗可在小鼠中诱导强烈的免疫应答。
Virol Sin. 2024 Aug;39(4):675-684. doi: 10.1016/j.virs.2024.07.002. Epub 2024 Jul 10.
3
Human norovirus cultivation systems and their use in antiviral research.

本文引用的文献

1
Pathogenesis of Human Norovirus Genogroup II Genotype 4 in Post-Weaning Gnotobiotic Pigs.断奶后无菌仔猪中人类诺如病毒II基因组4型的发病机制
J Microbiol Biotechnol. 2018 Dec 28;28(12):2133-2140. doi: 10.4014/jmb.1809.09061.
2
Human Monoclonal Antibodies That Neutralize Pandemic GII.4 Noroviruses.中和大流行 GII.4 诺如病毒的人源单克隆抗体。
Gastroenterology. 2018 Dec;155(6):1898-1907. doi: 10.1053/j.gastro.2018.08.039. Epub 2018 Aug 28.
3
Vesicle-Cloaked Virus Clusters Are Optimal Units for Inter-organismal Viral Transmission.
人类诺如病毒培养系统及其在抗病毒研究中的应用。
J Virol. 2024 Apr 16;98(4):e0166323. doi: 10.1128/jvi.01663-23. Epub 2024 Mar 12.
4
Common and Potential Emerging Foodborne Viruses: A Comprehensive Review.常见及潜在新出现的食源性病毒:综述
Life (Basel). 2024 Jan 28;14(2):190. doi: 10.3390/life14020190.
5
Nanocellulose-Based Passivated-Carbon Quantum Dots (P-CQDs) for Antimicrobial Applications: A Practical Review.用于抗菌应用的纳米纤维素基钝化碳量子点(P-CQDs):实用综述
Polymers (Basel). 2023 Jun 12;15(12):2660. doi: 10.3390/polym15122660.
6
Searching for a Reliable Viral Indicator of Faecal Pollution in Aquatic Environments.寻找水生环境中粪便污染的可靠病毒指标。
J Microbiol. 2023 Jun;61(6):589-602. doi: 10.1007/s12275-023-00052-6. Epub 2023 Jun 1.
7
Lactobacilli as a Vector for Delivery of Nanobodies against Norovirus Infection.乳酸杆菌作为递送抗诺如病毒感染纳米抗体的载体
Pharmaceutics. 2022 Dec 25;15(1):63. doi: 10.3390/pharmaceutics15010063.
8
Recovery Infectious Enterovirus 71 by Bac-to-Bac Expression System and .通过杆状病毒表达系统恢复肠道病毒71型及……(原文此处不完整)
Front Microbiol. 2022 Feb 25;13:825111. doi: 10.3389/fmicb.2022.825111. eCollection 2022.
9
Epidemiology and evolution of Norovirus in China.诺如病毒在中国的流行病学和进化。
Hum Vaccin Immunother. 2021 Nov 2;17(11):4553-4566. doi: 10.1080/21645515.2021.1961465. Epub 2021 Sep 8.
10
Noroviruses-The State of the Art, Nearly Fifty Years after Their Initial Discovery.诺如病毒——近五十年来的研究进展。
Viruses. 2021 Aug 4;13(8):1541. doi: 10.3390/v13081541.
囊泡包裹的病毒簇是进行种间病毒传播的最佳单位。
Cell Host Microbe. 2018 Aug 8;24(2):208-220.e8. doi: 10.1016/j.chom.2018.07.006.
4
A Single Nucleoside Viral Polymerase Inhibitor Against Norovirus, Rotavirus, and Sapovirus-Induced Diarrhea.一种针对诺如病毒、轮状病毒和星状病毒引起的腹泻的单核苷酸病毒聚合酶抑制剂。
J Infect Dis. 2018 Oct 20;218(11):1753-1758. doi: 10.1093/infdis/jiy398.
5
Human Norovirus Replication in Human Intestinal Enteroids as Model to Evaluate Virus Inactivation.人类诺如病毒在人类肠类器官中的复制作为评估病毒失活的模型。
Emerg Infect Dis. 2018 Aug;24(8):1453-1464. doi: 10.3201/eid2408.180126.
6
Safety and immunogenicity of an oral tablet norovirus vaccine, a phase I randomized, placebo-controlled trial.口服诺如病毒疫苗的安全性和免疫原性:一项 I 期随机、安慰剂对照试验。
JCI Insight. 2018 Jul 12;3(13):121077. doi: 10.1172/jci.insight.121077.
7
Development of an infectious clone and replicon system of norovirus GII.4.开发一种诺如病毒 GII.4 的感染性克隆和复制子系统。
J Virol Methods. 2018 Aug;258:49-53. doi: 10.1016/j.jviromet.2018.05.011. Epub 2018 May 22.
8
More robust gut immune responses induced by combining intranasal and sublingual routes for prime-boost immunization.经鼻内和舌下途径联合进行初免-加强免疫可诱导更强烈的肠道免疫应答。
Hum Vaccin Immunother. 2018;14(9):2194-2202. doi: 10.1080/21645515.2018.1472185. Epub 2018 Jun 19.
9
Targeting macrophage- and intestinal epithelial cell-specific microRNAs against norovirus restricts replication in vivo.针对巨噬细胞和肠上皮细胞特异性 microRNAs 可限制诺如病毒在体内的复制。
J Gen Virol. 2018 Dec;99(12):1621-1632. doi: 10.1099/jgv.0.001065. Epub 2018 Apr 23.
10
Parenterally Administered Norovirus GII.4 Virus-Like Particle Vaccine Formulated with Aluminum Hydroxide or Monophosphoryl Lipid A Adjuvants Induces Systemic but Not Mucosal Immune Responses in Mice.铝氢氧化物或单磷酰脂质 A 佐剂配制的肠道外给予的诺如病毒 GII.4 病毒样颗粒疫苗在小鼠中诱导全身而非粘膜免疫应答。
J Immunol Res. 2018 Feb 28;2018:3487095. doi: 10.1155/2018/3487095. eCollection 2018.